WST West Pharmaceutical Services

8-K Current Report

Filed: March 9, 2026

Health Care

Surgical & Medical Instruments & Apparatus

West Pharmaceutical Services (WST) 8-K current report filed with SEC EDGAR on March 9, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

Item 5.02: Departure/Election of Directors or Officers
Item 7.01: Regulation FD Disclosure

AI Filing Analysis
8-K

Item 5.02 · Departure/Election of Directors or Officers

• CEO Eric M. Green retiring as President, CEO, and Board Chair once successor hired — transition expected H2 2026
• Board engaging executive search firm; leadership continuity risk elevated during search period

+1 more insights

Item 7.01 · Regulation FD Disclosure

• CEO Eric Green announced intent to retire from West Pharmaceutical Services and its Board of Directors
• Company reaffirmed full-year 2026 financial guidance originally issued in Feb 12, 2026 earnings release

+2 more insights

Get deeper insights on West Pharmaceutical Services

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.